BioRestorative Therapies, Inc. (BRTX) DCF Valuation

BioRestorative Therapies, Inc. (BRTX) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

BioRestorative Therapies, Inc. (BRTX) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify BioRestorative Therapies, Inc. (BRTX) valuation with this customizable DCF Calculator! Featuring real BioRestorative Therapies, Inc. (BRTX) financials and adjustable forecast inputs, you can test scenarios and uncover BioRestorative Therapies, Inc. (BRTX) fair value in minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .1 .1 .0 .1 .1 .2 .2 .2 .2 .2
Revenue Growth, % 0 -40.77 -40.26 160.43 21.7 10.17 10.17 10.17 10.17 10.17
EBITDA -9.3 -9.5 -26.2 -18.9 -15.1 -.2 -.2 -.2 -.2 -.2
EBITDA, % -7147.23 -12312.44 -56997.32 -15737.46 -10325.82 -100 -100 -100 -100 -100
Depreciation .2 .2 .2 .1 .2 .2 .2 .2 .2 .2
Depreciation, % 167.27 197.35 446.1 100.62 113.67 100 100 100 100 100
EBIT -9.5 -9.6 -26.4 -19.0 -15.2 -.2 -.2 -.2 -.2 -.2
EBIT, % -7314.5 -12509.79 -57443.41 -15838.08 -10439.49 -100 -100 -100 -100 -100
Total Cash .0 3.1 21.0 14.7 11.1 .1 .1 .2 .2 .2
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 24.62 22.08 10.87 13.36 13.24
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 0 0.0012987 0 0.000834724541 0 0.000426685168 0.000426685168 0.000426685168 0.000426685168 0.000426685168
Accounts Payable 2.0 .1 .1 .2 .2 .2 .2 .2 .2 .2
Accounts Payable, % 1503.41 154.35 110.49 142.66 129.9 100 100 100 100 100
Capital Expenditure .0 .0 .0 -.4 -.2 -.1 -.1 -.1 -.1 -.1
Capital Expenditure, % -27.41 0 -66.65 -367.46 -117.31 -58.81 -58.81 -58.81 -58.81 -58.81
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -11.6 -10.5 -17.9 -18.5 -15.2 -.1 -.2 -.2 -.2 -.2
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -9.5 -12.1 -17.7 -18.7 -15.2 -.1 -.1 -.1 -.1 -.1
WACC, % 293.79 293.79 293.76 293.79 293.79 293.78 293.78 293.78 293.78 293.78
PV UFCF
SUM PV UFCF .0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -1
Equity Value 1
Diluted Shares Outstanding, MM 4
Equity Value Per Share 0.16

What You Will Get

  • Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: BioRestorative Therapies, Inc. (BRTX) financial data pre-loaded to facilitate your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically for you.
  • Customizable and Professional: A refined Excel model that adjusts to meet your valuation requirements.
  • Built for Analysts and Investors: Perfect for assessing projections, validating strategies, and enhancing efficiency.

Key Features

  • Customizable Treatment Parameters: Adjust key metrics such as patient outcomes, treatment costs, and recovery times.
  • Instant Clinical Evaluation: Provides immediate assessments of treatment effectiveness and potential benefits.
  • High-Precision Results: Utilizes real-world data from BioRestorative Therapies, Inc. (BRTX) for accurate analysis.
  • Streamlined Scenario Testing: Easily explore various treatment options and assess their impacts.
  • Efficiency Booster: Remove the complexity of developing intricate treatment models from the ground up.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based BRTX Valuation Model.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth projections, discount rates, profit margins, and more.
  3. Instant Calculations: The model automatically recalculates the intrinsic value of BioRestorative Therapies, Inc. (BRTX).
  4. Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
  5. Analyze and Decide: Leverage the findings to inform your investment or financial strategy.

Why Choose BioRestorative Therapies, Inc. (BRTX)?

  • Innovation: Cutting-edge therapies backed by extensive research and development.
  • Expertise: Team of professionals with deep knowledge in regenerative medicine.
  • Accessibility: Solutions designed to be user-friendly for both practitioners and patients.
  • Commitment: Dedicated to improving patient outcomes through advanced biotechnologies.
  • Trustworthiness: Transparent operations and adherence to regulatory standards.

Who Should Use This Product?

  • Healthcare Investors: Develop comprehensive valuation models for assessing biotechnology investments.
  • Corporate Development Teams: Evaluate valuation scenarios to inform strategic decisions within the biotech sector.
  • Consultants and Advisors: Deliver precise valuation insights for BioRestorative Therapies, Inc. (BRTX) to clients.
  • Students and Educators: Utilize real-world biotech data to enhance learning and financial modeling skills.
  • Biotech Enthusiasts: Gain insights into the valuation processes of innovative companies like BioRestorative Therapies, Inc. (BRTX).

What the Template Contains

  • Historical Data: Includes BioRestorative Therapies, Inc.'s (BRTX) past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate BioRestorative Therapies, Inc.'s (BRTX) intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of BioRestorative Therapies, Inc.'s (BRTX) financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

No products were found matching.